|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.5500 - 3.7900|
|52 Week Range||0.6800 - 5.8000|
|Beta (3Y Monthly)||3.49|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MariMed Inc. (MRMD), a leading multi-state cannabis operator, today announced the formation of MariMed Hemp, Inc., a wholly-owned subsidiary to be entirely focused on hemp-derived CBD products. MariMed Hemp will have a dedicated executive team, proprietary brand and product lines, and distribution and marketing relationships, all separate from MariMed’s core cannabis business. The subsidiary builds on MariMed’s recent investment in GenCanna Global, a leader in high-quality, fully compliant hemp cultivation and processing which is acclaimed for its genetics, proprietary cultivation practices and best in class processing procedures that produce world class, GMP, quality CBD isolates and oils.
NEW YORK and TORONTO , Jan. 11, 2019 /PRNewswire/ -- The Canadian Securities Exchange (CSE), a Canadian listing exchange recognized as a Qualified Foreign Exchange in the U.S., Kapoor Kapital, and OTC ...
Norwood, MA and MIAMI, Jan. 10, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD) CEO Robert Fireman will be a featured presenter at the second annual Cannabis Capital Conference, hosted by premier financial media outlet Benzinga, to be held in Miami, Florida, Jan. 15-16, 2019. Fireman’s MariMed presentation will be at 1:50 pm in Ballroom 3 at Eden Roc Hotel-Miami Beach, 4525 Collins Avenue, Miami Beach, Fla. Mr. Fireman, who grew MariMed from its early stages to a multi-state, publicly traded cannabis organization that was one of the top performing cannabis stocks of 2018, will be in good company with presenters including top investors like CNBC's Tim Seymour, Jon Najarian and New Cannabis Ventures founder Alan Brochstein and other top cannabis company CEOs.
CORAL GABLES, FL / ACCESSWIRE / December 31,2018 / This year has been a year which has seen significant market volatility, but the healthcare sector has managed to remain above the curve by constantly working to design and implement innovative approaches to medical care for patients suffering from a variety of serious illnesses. As experts and professionals in the field have worked on developing technologies to improvequality of care available for consumers, the healthcare industry, as a whole, has seen tremendous growth. Premier Health Group (PHGRF) (PHGI), Axsome Therapeutics Inc (AXSM), Marimed Inc (MRMD), and Marker Therapeutics Inc (MRKR) are 4 healthcare companies worth keeping tabs on as we head into the new year.
CORAL GABLES, FL/ ACCESSWIRE / December 26, 2018 / While all other sectors of the market are concerned with high volatility, the cannabis industry has enjoyed positive gains as a result of recent legislation passed that will allow producers to ramp up production to meet the needs of consumers in the space. Premier Health Group (PHGRF) (PHGI), MariMed Inc (MRMD), New Age Beverages Corp (NBEV), and CV Sciences, Inc (CVSI) are 4 pot stocks to pay attention to as we approach the new year. Premier Health Group (PHGRF) (PHGI) saw its company shares enjoy a 2.87% boost in midday trading on Wednesday afternoon, trading at $0.64 per share, up from $0.53 at the end of October and $0.59 on December 9.
The Hemp CBD Era officially begins with the 2018 Farm Bill signed into law today by President Trump, according to MariMed, Inc. The landmark legislation, which legalizes industrial hemp, opens doors for MariMed, GenCanna Global (GenCanna) and other US businesses to meet soaring demand for Hemp CBD that analysts expect to grow from today’s $800 million to $22 billion by 2022. For the past few years, demand for CBD has far outpaced supply, as consumers discovered CBD’s efficacy for treating a range of medical conditions, including pediatric epilepsy, some cancers (and painful cancer treatments), acute anxiety, arthritic and chronic pain, high blood pressure, and various skin conditions, including acne.
CORAL GABLES, FL / ACCESSWIRE / December 17, 2018 / Since California first passed a proposition legalizing marijuana for medical purposes more than 20 years ago, medical marijuana has seen a rise in state and public support. Marijuana stocks have recently gotten more attention as industry growth continues to prosper. Cannabis has been approved for medical use in 33 states, as of November 2018, and is used to treat symptoms associated with diseases such as AIDS, cancer, and glaucoma.
CORAL GABLES, FL / ACCESSWIRE / December 14, 2018 / The United States Senate and House passed the 2018 Farm Bill this week thus paving the way for CBD and hemp legalization. Hemp products are made in America, sold in America, and consumed in America.
As President Trump prepares to sign the 2018 Farm Bill into law in coming days, MariMed, Inc. “The expected signing of the Farm Bill will enable Americans to enjoy legal access to a host of hemp-derived CBD-based solutions, which are already renowned for their health and wellness benefits, ,” said Robert Fireman, MariMed CEO. “MariMed expects to make a series of Hemp CBD product and distribution announcements in 2019.
NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
The pendulum of cannabis legalization in the US seems to have begun to swing back towards a positive stance over the first half of 2018. With the rise of cannabis legalization across North America, has come with it a rise in the prevalence of niche expertise in the sector.
NORWOOD, MA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD), a multi-state cannabis operator, reported third quarter 2018 financial results for the quarter and nine months ended September 30, 2018. The Company continued to grow quarterly year-over-year revenue since the second quarter of 2016. Operating income increased 75% to approximately $2.0 from approximately $1.1 million during the nine months ended September 30, 2017.
CORAL GABLES, FL / ACCESSWIRE / November 7,2018 / Medical cannabis and recreational marijuana have been put in a very bright spotlight on Wednesday. Missouri and Utah approved medical marijuana initiatives, joining 31 other states that already allow prescription sales. ICC International Cannabis Corp. (KNHBF) (WRLD) a has held its trading level around $0.50 for the last week and on the heels of major marijuana market developments, the company announced today that it has received an inaugural purchase order for 10,000mL of Tetrahydrocannabinol Cannabis oil, 5,000g of dried Cannabis flower and 5,000mL of Cannabidiol oil.
Finnie to lead MariMed M&A, strategic investment, corporate strategy, investor relations Finnie sees biggest opportunity in undervalued US cannabis companies NORWOOD,.
HENDERSON, NV / ACCESSWIRE / November 6, 2018 / As the stock market plummeted early October cannabis companies stayed strong, buoyed up by legislative changes in Canada. The cannabis market appears set ...
MariMed Inc., a multi-state cannabis organization that develops, owns and manages cannabis facilities and branded products lines, announced today that it has finalized the acquisition of BSC Group, a highly respected cannabis firm headquartered in New Jersey that over the last three years has been engaged in competitive licensing, consulting and operations management across the country. BSC founders and managing partners, Brian Staffa and Amber Staffa, will join the MariMed leadership team, bringing under the MariMed umbrella their extensive cannabis expertise, resources, intellectual property and a vast network of highly specialized affiliates spanning regulated fields of commercial cannabis, food and beverage, commercial agriculture, pharmaceuticals, regulatory compliance, consumer psychology, and the applied sciences.
HENDERSON, NV / ACCESSWIRE / October 24, 2018 / While many equities took losses on Tuesday one stock we found nearly doubled its price on the heels of some huge news. OriginClear, Inc. (OCLN) started what ...
HENDERSON NV / ACCESSWIRE / October 11, 2018 / Some of the world's biggest beverage makers are looking to add cannabis-infused drinks to their lineups. Corona brewer Constellation Brands said last month ...
NEW YORK, NY / ACCESSWIRE / October 11, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
CORAL GABLES, FL / ACCESSWIRE / October 5, 2018 / The cannabis market is attracting many new investors recently and the upcoming Canadian legalization has spawned added growth for marijuana stocks. The Drug Enforcement Administration recently placed Epidiolex, a drug that includes cannabis-derived compounds - specifically, cannabidiol (CBD) - in Schedule V. The DEA move takes a broad look at how the FDA is conducting its business, placing "certain drug products that have been approved by the [FDA] and which contain [CBD] in schedule V of the Controlled Substances Act (CSA)," according to the DEA order.